Can we use a simple blood test to reduce unnecessary adverse effects from radiotherapy by timely identification of radiotherapy-resistant rectal cancers? MeD-Seq rectal study protocol

BACKGROUND: Chemoradiation therapy (CRT) followed by surgery is currently the standard of care to treat patients with locally advanced rectal cancer (LARC). CRT reduces local recurrences, but is associated with significant damage to the surrounding healthy tissue that can severely impact patients qu...

Descripción completa

Detalles Bibliográficos
Autores principales: Mens, D. M., van Rees, J. M., Wilting, S. M., Verhoef, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696698/
https://www.ncbi.nlm.nih.gov/pubmed/38049783
http://dx.doi.org/10.1186/s12885-023-11671-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696698/
https://www.ncbi.nlm.nih.gov/pubmed/38049783
http://dx.doi.org/10.1186/s12885-023-11671-y

Ejemplares similares